Skip to main content
Figure 3 | BMC Nephrology

Figure 3

From: BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition

Figure 3

Donor/Recipient CMV risk profiles in patients with (grey bars) and without BK-viremia (white bars, Figure 3 A). Creatinine course at the time of discharge as well as 3 and 12 months after transplantation in patients with (grey bars) and without BK-viremia (white bars; Figure  3 B). Only patients with complete creatinine values at all time points were included.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us